TABUTEAU HERRIOT (CIK 1219927) reported 40 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy AXSM (45,004 shares), Sell AXSM (45,004 shares), Buy AXSM (4,660 shares), Sell AXSM (4,660 shares), Buy AXSM (49,666 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 45,004 | $222,770 |
| 2026-08-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 45,004 | $9.5M |
| 2026-08-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 4,660 | $23,067 |
| 2026-08-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 4,660 | $997,007 |
| 2026-07-01 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 49,666 | $245,847 |
| 2026-07-01 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 49,666 | $11.9M |
| 2026-06-09 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 49,670 | $245,866 |
| 2026-06-09 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 49,670 | $12.0M |
| 2026-02-02 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 32,410 | $259,928 |
| 2026-02-02 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 32,410 | $6.0M |
| 2026-01-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 29,450 | $236,189 |
| 2026-01-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 78,703 | $13.5M |
| 2026-01-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 78,703 | $631,198 |
| 2026-01-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 29,450 | $5.1M |
| 2026-01-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 31,261 | $250,713 |
| 2026-01-07 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 31,261 | $5.3M |
| 2025-12-04 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 49,252 | $395,001 |
| 2025-12-04 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 49,252 | $7.1M |
| 2025-12-04 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 20,163 | $161,707 |
| 2025-12-04 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 20,163 | $3.0M |
| 2025-12-04 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 10,558 | $84,675 |
| 2025-12-04 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 10,558 | $1.6M |
| 2025-11-05 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 91,705 | $735,474 |
| 2025-11-05 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Sell | 91,705 | $12.1M |
| 2025-11-05 | Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer | Buy | 50,459 | $404,681 |
Source: SEC Form 4 filings · as of 2026-08-07